Next Article in Journal
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
Next Article in Special Issue
Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers
Previous Article in Journal
Seasonal Variation and Geographical Distribution of COVID-19 across Nigeria (March 2020–July 2021)
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 296; https://doi.org/10.3390/vaccines11020296
Action Date Notes Link
article xml file uploaded 29 January 2023 14:34 CET Original file -
article xml uploaded. 29 January 2023 14:34 CET Update https://www.mdpi.com/2076-393X/11/2/296/xml
article pdf uploaded. 29 January 2023 14:34 CET Version of Record https://www.mdpi.com/2076-393X/11/2/296/pdf
article supplementary file uploaded. 29 January 2023 14:34 CET - https://www.mdpi.com/2076-393X/11/2/296#supplementary
article html file updated 29 January 2023 14:36 CET Original file -
article html file updated 8 March 2023 20:11 CET Update https://www.mdpi.com/2076-393X/11/2/296/html
Back to TopTop